David Luque-Paz
Overview
Explore the profile of David Luque-Paz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chean D, Luque-Paz D, Poole D, Fodil S, Lengline E, Dupont T, et al.
Ann Intensive Care
. 2025 Jan;
15(1):9.
PMID: 39821042
Background: To describe the use of life-sustaining therapies and mortality in patients with acute leukemia admitted to the intensive care unit (ICU). Methods: The PubMed database was searched from January...
2.
Guirriec Y, Luque-Paz D, Bernard G, Mabo A, Kerjouan M, Menard C, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39624377
Background: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease that may progress towards pulmonary fibrosis. Data about fibrosis prevalence and risk factors are lacking. Methods: In this retrospective multicentre...
3.
Meschiari M, Asquier-Khati A, Tiseo G, Luque-Paz D, Murri R, Boutoille D, et al.
Int J Antimicrob Agents
. 2024 Apr;
64(1):107186.
PMID: 38688353
Introduction: The emergence of multidrug-resistant Gram-negative bacilli and the development of new antibiotics have complicated the selection of optimal regimens. International guidelines are valuable tools, but are limited by the...
4.
Luque-Paz D, Lalanne S, Besombes J, Dorel M, Maamar A, Revest M
J Antimicrob Chemother
. 2024 Apr;
79(6):1462-1463.
PMID: 38557693
No abstract available.
5.
Le Moulec J, Picard L, Belaz S, Couturier A, Revest M, Tattevin P, et al.
J Mycol Med
. 2023 Dec;
34(1):101454.
PMID: 38042014
No abstract available.
6.
Letellier A, Rolland-Debord C, Luque-Paz D, Milon A, Choinier P, Blin E, et al.
Respir Med Res
. 2023 Oct;
84:101054.
PMID: 37897878
Background And Objectives: Krebs von den Lungen-6 (KL-6), expressed by damaged type II pneumocytes, is useful in the diagnosis and severity assessment of many diffuse interstitial lung diseases. The objective...
7.
Luque-Paz D, Verdier M, Lefevre C, Chauvin P, Goter T, Armange L, et al.
Int J Antimicrob Agents
. 2023 Oct;
62(6):107004.
PMID: 37839716
Objectives: The pharmacokinetics of antibiotics in pleural fluid during pleural infections has been poorly described. This study aimed to explore amoxicillin and metronidazole diffusion into the pleural space. Methods: This...
8.
Luque-Paz D, Turban A, Tattevin P, Cattoir V
Intensive Care Med
. 2023 Sep;
49(11):1433-1434.
PMID: 37725116
No abstract available.
9.
Turban A, Gaubert S, Luque-Paz D, Rene C, Collet N, Pawlowski M, et al.
Pract Lab Med
. 2023 Jul;
36:e00317.
PMID: 37425622
No abstract available.
10.
Luque-Paz D, Cuervo G, Miro J, Tattevin P
Clin Microbiol Infect
. 2023 Mar;
29(6):676-678.
PMID: 36889644
No abstract available.